JEADV Clinical Practice (Sep 2023)

Excellent response to adalimumab in a patient with Papillon–Lefèvre syndrome: A case report

  • Eman Almukhadeb,
  • Wael Alanazi,
  • Rahaf Alshareef,
  • Feras Altukhaim,
  • Amal Albalbeesi

DOI
https://doi.org/10.1002/jvc2.184
Journal volume & issue
Vol. 2, no. 3
pp. 621 – 624

Abstract

Read online

Abstract Papillon–Lefèvre syndrome (PLS) is a rare autosomal recessive disease that presents clinically with palmoplantar keratoderma and periodontitis and results in early‐onset dental loss. PLS management is difficult. We report a 30‐year‐old female with PLS who had unfavourable response to topical keratolytic creams, oral isotretinoin and narrow‐band ultraviolet‐B (NB‐UVB) phototherapy but showed significant clinical improvement to adalimumab.

Keywords